Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma

Saved in:

Bibliographic Details
Main Authors:	Zhigang Ren, Xiaochao Ma, Zhenfeng Duan, Xinhua Chen
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Analytical Cellular Pathology
Online Access:	http://dx.doi.org/10.1155/2020/8157406
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis
by: Fengle Jiang, et al.
Published: (2025-01-01)

Targeted Therapy in Hepatocellular Carcinoma
by: Clarinda W. L. Chua, et al.
Published: (2011-01-01)

Emerging nanomedicine strategies for hepatocellular carcinoma therapy
by: Chen Guo, et al.
Published: (2024-09-01)

Clinical Characteristics and Surgical Prognosis of Hepatocellular Carcinoma with Bile Duct Invasion
by: Ke-Wei Meng, et al.
Published: (2014-01-01)

The Role of Bridging Therapy in Hepatocellular Carcinoma
by: Roberto Galuppo, et al.
Published: (2013-01-01)

To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma
by: Duangui Gao, et al.
Published: (2025-02-01)

Factors Affecting the Prognosis of Small Hepatocellular Carcinoma in Taiwanese Patients Following Hepatic Resection
by: Chih-Jan Ko, et al.
Published: (2011-01-01)

Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
by: Dongjing Zhang, et al.
Published: (2025-01-01)

TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
by: Zhikun Liu, et al.
Published: (2017-01-01)

Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus
by: Hatia RI, et al.
Published: (2025-01-01)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
by: Xiangjun Qi, et al.
Published: (2022-01-01)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
by: Yue Luo, et al.
Published: (2021-01-01)

The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma
by: Karim Y. A. Shaheen, et al.
Published: (2015-01-01)

Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma
by: Huai-Yu Wu, et al.
Published: (2025-01-01)

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01)

DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration
by: Yanni Xu, et al.
Published: (2020-01-01)

Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
by: Jianyan Pan, et al.
Published: (2025-02-01)

High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma
by: Haopeng Wen, et al.
Published: (2023-01-01)

Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
by: Ji Sun, et al.
Published: (2022-01-01)

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01)

Retracted: Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
by: Yu-Ling Chen, et al.
Published: (2013-01-01)

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
by: Xiao-Dong Sun, et al.
Published: (2016-01-01)

Dramatic Reduction in Tumour Size in Hepatocellular Carcinoma Patients on Thalidomide Therapy
by: Denny Demeria, et al.
Published: (2007-01-01)

Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01)

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01)

Epidemiology of Hepatocellular Carcinoma
by: Mimi C Yu, et al.
Published: (2000-01-01)

Biomarkers for Hepatocellular Carcinoma
by: Tara Behne, et al.
Published: (2012-01-01)

Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
by: Cunzhen Zhang, et al.
Published: (2025-01-01)

A Real-World Study of Prognosis of N0M0 Hepatocellular Carcinoma with Hepatic Resection Based on SEER Database
by: Guangxi Zhu, et al.
Published: (2020-01-01)

Real world study on combining local interventions with systemic therapy in unresectable hepatocellular carcinoma
by: Zhaosong Xue, et al.
Published: (2025-02-01)

Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
by: Biling Gan, et al.
Published: (2025-02-01)

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma
by: Hideo Suzuki, et al.
Published: (2021-01-01)

Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma
by: Felix H. Shek, et al.
Published: (2012-01-01)

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
by: Qinxue Sun, et al.
Published: (2025-01-01)

Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy
by: Min Guo, et al.
Published: (2022-01-01)

The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study
by: Chendong Yuan, et al.
Published: (2025-01-01)

Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma
by: Mei Liu, et al.
Published: (2014-01-01)

Hepatocellular Carcinoma to the Right Ventricle
by: George R. Marzouka, et al.
Published: (2014-01-01)

Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma
by: Dongqian Li, et al.
Published: (2024-01-01)